Tenecteplase—What Have We Learned till Now? A Narrative Review

Tenecteplase (TNK), a genetically modified tissue plasminogen activator, has emerged as a promising alternative to alteplase (ALT) for intravenous thrombolysis (IVT) in acute ischemic stroke (AIS). Our aim was to synthesize the current clinical evidence on TNK use in AIS patients, comparing efficacy...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Matija Zupan, Lara Straus, Pawel Kermer, Senta Frol
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI AG 2025-08-01
श्रृंखला:Life
विषय:
tenecteplase
acute ischemic stroke
treatment
narrative review
alteplase
ऑनलाइन पहुंच:https://www.mdpi.com/2075-1729/15/9/1356
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन